Atlas FDA

Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)

FDA premarket approval P110042/S174 · decided 2022-12-12

Approval details

PMA number
P110042
Supplement
S174
Supplement type
Real-Time Process
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)
Generic name
Implantable cardioverter defibrillator (non-CRT)
Applicant
Boston Scientific Corporation
Date received
2022-09-30
Decision date
2022-12-12
Days to decision
73 days
Decision code
APPR
Product code
LWS
Advisory committee
Cardiovascular
Expedited review
No
Location
St Paul, MN
Statement
Approval for modifications to the product labeling for the Accolade family of pacemakers and cardiac resynchronization therapy pacemakers to provide additional clarity.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
TheraSphere 360™ Y-90 Management Platform (K262462)Boston Scientific Corporation2026-07-24
FARADRIVE™ Steerable Sheath (M004PF21M402) (K262165)Boston Scientific Corporation2026-07-24
OBSIDIO Conformable Embolic (K261488)Boston Scientific Corporation2026-07-24
WallFlex Esophageal Stent System;Agile Esophageal Over-the-Wire (OTW) Stent System (K261978)Boston Scientific Corporation2026-07-10
RIVOS™ EUS Access Device (M00553900) (K260428)Boston Scientific Corporation2026-06-17
MOSES Raydar™ (K260100)Boston Scientific Corporation2026-05-18
TruSelect™ 2.6 Microcatheter (K260771)Boston Scientific Corporation2026-05-15
Asurys Fluid Management System (K251273)Boston Scientific Corporation2026-03-27